Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

Clicks: 347
ID: 117748
2000
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
This heptavalent pneumococcal conjugate appears to be highly effective in preventing invasive disease in young children and to have a significant impact on otitis media.
Reference Key
s2000theefficacy, Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Black S;Shinefield H;Fireman B;Lewis E;Ray P;Hansen JR;Elvin L;Ensor KM;Hackell J;Siber G;Malinoski F;Madore D;Chang I;Kohberger R;Watson W;Austrian R;Edwards K;;
Journal the pediatric infectious disease journal
Year 2000
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/10749457
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine Infant risk factors Clinical Trial Randomized Controlled Trial Double-Blind Method vaccines serotyping streptococcus pneumoniae / immunology* conjugate / immunology conjugate / adverse effects otitis media / microbiology bacterial vaccines / administration & dosage bacterial vaccines / immunology* pneumococcal infections / prevention & control pmid:10749457 doi:10.1097/00006454-200003000-00003 s black h shinefield k edwards bacterial vaccines / adverse effects consumer product safety otitis media / prevention & control* pneumococcal infections / immunology* conjugate / administration & dosage

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.